anti-integrin
IBD Clinical Trials at a Crossroads
Inflammatory bowel disease clinical trials are facing headwinds, with challenges in recruitment and trial design.
OCTOBER 22, 2024

The ABCs of Optimizing Drug Sequencing for IBD
The number of inflammatory bowel disease treatment options with different mechanisms of action has exploded over ...
OCTOBER 13, 2024

Equipoise at Risk With Placebo-Controlled Trials
The standard approach to randomized clinical trials for moderate to severe IBD causes harm to participants, ...
MAY 21, 2024

Dual-Targeted Therapy in IBD Not Yet Ready for Prime Time
More evidence on the safety and efficacy of dual-targeted therapy for IBD is needed, according to presentations at ...
MARCH 20, 2023
